Mumbai, Sept. 20 -- Lupin announced that USFDA has conducted a product-specific Pre-Approval Inspection at the Company's Pune Biotech facility from 08 September to 19 September 2025. The inspection closed with four

observations.

Published by HT Digital Content Services with permission from Capital Market....